Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
a.k.a Brands | AKA | Jan 16, 2025 | 17.00 | -2.75 |
A.O Smith | AOS | Jan 16, 2025 | 71.40 | +0.63 |
A10 Networks | ATEN | Jan 16, 2025 | 18.72 | -0.37 |
A2Z Cust2Mate Solutions | AZ | Jan 16, 2025 | 6.98 | +9.40 |
AA Mission Acquisition | AAM | Jan 16, 2025 | 10.12 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Jan 16, 2025 | 46.73 | +0.15 |
Aadi Bioscience | AADI | Jan 16, 2025 | 3.13 | -3.40 |
AAON | AAON | Jan 16, 2025 | 131.53 | +1.22 |
AAR | AIR | Jan 16, 2025 | 70.61 | +1.58 |
Abacus Life | ABL | Jan 16, 2025 | 7.38 | -1.60 |
Abbott Laboratories | ABT | Jan 16, 2025 | 113.91 | +2.53 |
AbbVie | ABBV | Jan 16, 2025 | 173.70 | +1.37 |
AbCellera Biologics | ABCL | Jan 16, 2025 | 2.94 | -0.68 |
Abeona Therapeutics | ABEO | Jan 16, 2025 | 5.24 | -1.13 |
Abercrombie & Fitch | ANF | Jan 16, 2025 | 128.11 | -1.45 |
Aberdeen Asia-Pacificome Fund | FAX | Jan 16, 2025 | 15.28 | -0.26 |
Aberdeen Australia Equity Fund | IAF | Jan 16, 2025 | 4.37 | -0.11 |
Aberdeen Emerging Markets Fund | AEF | Jan 16, 2025 | 5.14 | +0.19 |
Aberdeen Global Fund | FCO | Jan 16, 2025 | 5.92 | -1.00 |
Aberdeen Global Infrastructure | ASGI | Jan 16, 2025 | 18.04 | +2.09 |
Aberdeen Income Credit Strategies Fund | ACP | Jan 16, 2025 | 6.10 | +0.49 |
Aberdeen Income Credit Strategies Pref | ACP-A | Jan 16, 2025 | 21.85 | +0.18 |
Aberdeen Japan Equity Fund | JEQ | Jan 16, 2025 | 5.61 | -0.71 |
Abits Group | ABTS | Jan 16, 2025 | 0.51 | +4.04 |
Abivax SA - American Depositary Shares | ABVX | Jan 16, 2025 | 6.23 | -0.95 |
Able View Global | ABLV | Jan 16, 2025 | 1.02 | -5.80 |
ABM Industries | ABM | Jan 16, 2025 | 53.37 | +0.79 |
Above Food Ingredients | ABVE | Jan 16, 2025 | 0.60 | +16.96 |
Abpro Holdings | ABP | Jan 16, 2025 | 1.35 | 0.00 |
Abrdn Global Dynamic Dividend Fund | AGD | Jan 16, 2025 | 10.14 | +0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.